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The molecular circuitries controlling the process of skin
wound healing have gained new significant insights in
recent years. This knowledge is built on landmark stud-
ies on skin embryogenesis, maturation, and differentia-
tion. Furthermore, the identification, characterization,
and elucidation of the biological roles of adult skin epi-
thelial stem cells and their influence in tissue homeosta-
sis have provided the foundation for the overall
understanding of the process of skin wound healing and
tissue repair. Among numerous signaling pathways asso-
ciated with epithelial functions, the PI3K/Akt/mTOR sig-
naling route has gained substantial attention with the
generation of animal models capable of dissecting indi-
vidual components of the pathway, thereby providing a
novel insight into the molecular framework underlying
skin homeostasis and tissue regeneration. In this review,
we focus on recent findings regarding the mechanisms
involved in wound healing associated with the upregula-
tion of the activity of the PI3K/Akt/mTOR circuitry.
This review highlights critical findings on the molecular
mechanisms controlling the activation of mTOR, a
downstream component of the PI3K–PTEN pathway,
which is directly involved in epithelial migration and
proliferation. We discuss how this emerging information
can be exploited for the development of novel pharma-
cological intervention strategies to accelerate the heal-
ing of critical size wounds.
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Introduction
The skin is the largest organ in the body, with remarkable
implications in physiology and homeostasis. Its main pur-
pose is to maintain a barrier function, which prevents the
loss water and protects the body against biological, physi-
cal, and chemical insults. Moreover, a healthy skin plays a
crucial esthetical role, and often contributes to our social
interactions and overall feeling of well-being (Elias, 1983;
Elias and Choi, 2005; Proksch et al, 2008; Fuchs, 2009).
These key functions require the integrity of the epidermal
barrier. Upon injury, the fast response of the immune sys-
tem, the deposition of a provisional matrix, and the coor-
dinated engagement of all cellular components of the
epidermis, including their tissue repopulating stem cells
are required for the rapid reestablishment of local homeo-
stasis (Woodley et al, 1993; Singer and Clark, 1999; Elias
and Choi, 2005; Fuchs and Nowak, 2008). Such capacity
to heal injured tissues, however, may be compromised by
large size wounds and can be aggravated by the presence
of infections and medical conditions. This review presents
an epitheliocentric view of the complex process of wound
healing, with a special focus on the PI3K-mTOR signaling
pathway, whose pharmacological perturbation can be
exploited to promote accelerated epithelial healing.
The epidermis
The skin is formed during embryogenesis in a liquid inter-
face with the amniotic ﬂuid. Initial characteristics of skin
are observed as early as 30 days after the estimated gesta-
tional age. By 6 weeks, the skin of a human embryo
already shows a well-deﬁned epidermis and dermis, tissue
innervation and vascularization (Holbrook, 2011). The
embryonic epidermis is composed by only two layers of
epithelial cells separated from the dermis by a continuous
basal lamina (Marinkovich et al, 1993). During the second
trimester, the skin presents a much-improved organization
with the development of appendances that progressively
start to gain function.
During embryogenesis, studies using murine animal
models have revealed two distinct phases of cell division
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in the epidermis (Lechler and Fuchs, 2005). At embryonic
day 12.5 (E12.5), mice present most of the epidermis as a
single-cell layer, with the majority of the cellular divisions
occurring laterally (92% of cells), thereby reﬂecting the
direction of the rapidly growing embryo. Only a small
percentage of the cells undergo a cellular division pattern
with mitosis occurring perpendicular to the basal mem-
brane; the resulting daughter cells therefore start to settle
on top of the basal cells constituting the parabasal epithe-
lial layer of the epidermis. Soon after, by day E15.5, there
is a dramatic shift on the cellular division pattern with
more than 70% of the cells presenting spindles perpendic-
ular to the basal membrane. Such process results in asym-
metrical cellular division, and the detachment of daughter
cells from the basal membrane initiates the stratiﬁcation
process of the epidermis (Smart, 1970) (Poulson and
Lechler, 2010).
The postnatal epidermis is organized in stratiﬁed layers
presenting an outward progressive differentiation pattern
(McGrath and Uitto, 2010). Epidermal stratiﬁcation is
essential in the development of a mechanical barrier
against the external environment. The epidermis is com-
posed by (i) the basal cellular layers responsible for con-
ferring the regenerative capacity of the skin through the
activation of symmetrical and asymmetrical cellular divi-
sion during homeostasis or during the process of wound
healing; (ii) the spinous cells located above the basal cells
preceding the (iii) granular layer that is characterized by
the intracellular accumulation of granules of keratohyalin.
Finally, the (iv) stratum corneum is the outermost layer
from the epidermis characterized by the absence of nuclei
and cytoplasmatic organelles presenting ﬂat keratin and
ﬁlaggrin ﬁlaments. The last two stages of differentiation
observed in the epidermis (accumulation of keratohyalin
granules and accumulation of cross-linked ﬂat keratin ﬁla-
ments) are important steps in the formation of the protective
barrier of the skin mediated by an irreversible proteolytic
cascade (List et al, 2002) (Miller and List, 2012).
The PI3K/AKT/mTOR signaling circuitry in
skin development and homeostasis
The serine/threonine kinase AKT is an important compo-
nent of the phosphatidylinositol 3-kinase (PI3K) signaling
pathway. Overexpression and persistent activation of AKT
are driven by oncogenes, growth factors, and cytokines.
AKT activation converges in the phosphorylation of its
Thr308 and Ser473 residues and, in turn, active AKT con-
trols many cellular functions, ranging from cell growth
and survival, to cell metabolism and growth (Alessi et al,
1996) (Andjelkovic et al, 1997). AKT functions are nega-
tively regulated by molecules capable of antagonizing the
PI3K signaling. Perhaps one of the most studied regula-
tory mechanism impinging on PI3K is the phosphatase
PTEN (for phosphatase and tensin homolog deleted from
Chromosome 10) (Li et al, 1997) (Steck et al, 1997).
PTEN negatively regulates the PI3K pathway by convert-
ing phosphatidylinositol 3,4,5-triphosphate (PIP3) into
phosphatidylinositol 4,5-biphosphate (PIP2), thus further
restraining the activation status of AKT (Cantley and
Neel, 1999).
The loss of function approaches has unveiled the impor-
tant functions of AKT during skin development and main-
tenance. Double knockout for Akt1 and Akt2 genes
present translucent skin due to a proliferation impairment
of the basal epithelial layer. However, no signs of changes
in the differentiation pattern were observed. Double
knockout mice are viable presenting a Mendelian distribu-
tion of traits, which indicates that Akt signaling is not
essentially required during embryogenesis, but important
for the maintenance of the normal architecture and homeo-
stasis of the skin (Peng et al, 2003). Double knockout
mice for Akt1 and Akt2 also result in a deﬁcient activa-
tion of the mammalian target of Rapamycin (mTOR)
(Gingras et al, 2001) (Simpson and Parsons, 2001).
The function of AKT signaling during skin homeostasis
has been also indirectly demonstrated by Santos and col-
leagues in 2002 with the development of an animal model
expressing cytokeratin 10 targeted to the basal layer of the
epidermis driven by the bovine keratin K5 promoter (San-
tos et al, 2002). Cytokeratin 10 is an intermediated ﬁla-
ment protein directly associated to the differentiation of
the skin and found within the spinous layer of the epider-
mis. When expression of cytokeratin 10 was targeted to
the proliferative layer of the epidermis (basal layers), it
resulted in downregulation of the Akt activity along with
reduced cellular proliferation, epidermal hypoplasia, and
hyperkeratosis. These results support the physiological
role of AKT in the maintenance of a viable and prolifera-
tive epidermis with preservation of the skin architecture.
Indeed, the role of AKT during skin homeostasis have
been partially addressed by the work of Paramio et al
where endogenous Akt was shown to interact with cyto-
keratin 10 (Paramio et al, 2001). Such interaction suggests
that cytokeratin 10 regulates the translocation of AKT to
the cell membrane, thereby preventing its activation by phos-
phorylation of the activation-loop threonine (Thr308), thus
promoting the differentiation process of the spinous layer
(CK10 positive cells) (Chou et al, 1998) (Kulik et al, 1997).
Gain of function assays have also helped the understand-
ing of the role of the PI3K signaling in skin biology.
Increased phosphorylation of AKT mediated by up regula-
tion of the PI3K signaling subunits p110a and p110b results
in the formation of a disorganized, hyperplastic, and poorly
differentiated epithelium in organotypic skin cultures as a
result of cytoskeleton reorganization, leading to an
increased cellular migratory phenotype (Pankow et al,
2006). Interestingly, expression of an active AKT instead of
the PI3K subunits results in growth arrest and differentiation
of epithelial cells, while pharmacological interference of
PI3K results in cell death and disruption of the machinery
responsible for epithelial differentiation (Calautti et al,
2005). Thus, the modulation of the PI3K signaling pathway
at the AKT level or upstream by the p110a and p110b PI3K
subunits directly inﬂuences the epithelial response indicat-
ing a much broader function of the PI3K pathway in the
control of skin homeostasis and probably wound healing.
Wound healing
As the largest organ in the human body, the skin homeo-
stasis is constantly disturbed by injuries affecting its most
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important function, the physical barrier. Such a role is
maintained through a continuous self-renewal process that
involves the maintenance of proliferative layer by epider-
mal stem cells (Oshima et al, 2001) (Tumbar et al, 2004)
and the orchestration of a terminal differentiation process
that involves the asymmetrical cellular division of basal
keratinocytes (Lechler and Fuchs, 2005).
Disruption of tissue integrity with complete loss of con-
tinuity of epithelial cells results in the activation of an
intricate process aiming at two distinct objectives: (i)
quick covering and protection of wounded area; and (ii)
regaining the skin protective functions by tissue prolifera-
tion, migration, and ultimately remodeling. This process is
mediated by an intricate mechanism that involves the for-
mation of the blood clot, deposition of extracellular matrix
(ECM) by stromal cells, and the induction of a well-regu-
lated process of epithelial migration. Overall, the process
of wound healing involves multiple interposed phases,
including inﬂammation, re-epithelialization, formation of
granulation tissue, vascularization, contraction, and ﬁnally,
tissue remodeling (Woodley et al, 1993).
The inﬂammation phase is directly associated to the
extravasation of blood to the wounded site and the for-
mation of a ﬁbrin clot, responsible for reestablishing tis-
sue homeostasis. Shortly, increased concentration of
growth factors initially secreted by platelets induces the
differentiation of monocytes into macrophages. These
cells are responsible for cleaning the wounded bed by the
phagocytosis of cellular debris, foreign bodies and patho-
gens, and the differentiation of ﬁbroblasts into myoﬁbro-
blasts, which are essential for the process of tissue
contraction (Singer and Clark, 1999). Short after the
inﬂammation phase, the process of re-epithelialization is
initially observed by the increase proliferation of the in-
terfollicular epidermis (Singer and Clark, 1999) and the
mobilization of hair follicle stem cells that migrate from
their niche toward the wounded area (Ito et al, 2007)
(Levy et al, 2007). The collaborative effort of the inter-
follicular and the follicular components of the skin during
the re-epithelialization phase are evident by the recent
characterization of the hair follicle stem cells as responsi-
ble for approximately 25% of cells found in the healed
skin (Ito et al, 2005). These cells are essential for the
accelerated healing during the initial phase of re-epitheli-
alization (Langton et al, 2008). Underneath the re-epithe-
lialization process, a new wound bed is formed by the
migration of newly recruited ﬁbroblasts and endothelial
cells along with macrophages that together form the gran-
ulation tissue. This process is essential for the continuous
migration of the epithelial cells and the progressive accu-
mulation of ECM and collagen deposition. The neovascu-
larization process then nurtures this newly formed
granulous tissue, with endothelial cells originally guided
by the deposition of ECM and angiogenic factors
released by the ﬁbroblasts. Finally, the differentiation of
ﬁbroblasts into myoﬁbroblasts marks the phase of wound
contraction and tissue remodeling that alone can take sev-
eral months to complete. Overall, the acute phase of
wound healing is fast and provides a protective barrier
early on in the process; however, full recovery of a
wounded area including tissue remodeling is a longer
process, which is often marked by a suboptimal recovery
of strength and appearance of the affected tissues.
The negative role of PI3K signaling in the control and
maintenance of skin homeostasis is evident during the
forced activation of oncogenes. Such process, known as
oncogene-induced senescence (OIS) has been previously
shown by our team (Castilho et al, 2009) to protect from
the process of malignization of the epidermis through
upregulation of mTOR function and the initiation of cell
senescence programs. In this case, inducible upregulation
of Wnt1 targeted to the basal layer of the skin using a cy-
tokeratin 5 promoter results in activation of cellular senes-
cence and differentiation of hair follicles, known to
represent an important reservoir of stem cells in the skin.
The process of cellular senescence in response to the con-
ditional Wnt1 expression was initially documented by the
overexpression of cytokeratin 10 in the hair follicles,
which is not observed in control littermates reﬂecting
increased cellular differentiation. Interestingly, mTOR
function was also found upregulated in the hair follicle of
transgenic mice expressing Wnt1 by the accumulation of
the phosphorylated form of the ribosomal protein S6, an
indirect downstream target of mTOR. Pharmacological
interference of this pathway using the mTOR-speciﬁc allo-
steric inhibitor rapamycin resulted in complete abrogation
of this phenotype, which demonstrated a new role of
mTOR in the maintenance of skin homeostasis and its
ability to trigger epithelial differentiation programs.
The PI3K/AKT/mTOR in wound healing
AKT
Numerous pathways and signaling networks have been
studied and implicated in the control of skin response after
injury. During normal wound healing in mice, we have
observed a progressive upregulation of the Akt phosphory-
lated at serine 473 (ser473) toward the wound edge com-
pared with the intact adjacent skin presenting a patched
expression of active Akt in the differentiated layer of the
epidermis (Squarize et al, 2010). Expression of Akt 473
subsequently extends to the spinous layer of the epidermis
(cytokeratin 10 positive) in the transitional skin next to
the epithelial tongue and is further expressed in all layers
of the epidermis in the migratory epithelial tongue. Similar
upregulation of Akt function during wound healing was
also observed in a tail model of wound healing. In this
model, overexpression of phosphorylated Akt was found
conﬁned to the proliferative and migratory areas of the
wound, where Akt phosphorylation remains restricted to
the outermost layer of the epidermis characterized by late
stage cellular differentiation (Pankow et al, 2006). Activa-
tion of Akt resulting in augmented epithelial migration
and proliferation is also observed upon disrupted contact
of epithelial cells with the underlining connective tissue as
observed in autoimmune blistering diseases (Pretel et al,
2009). Deletion of the ECM multidomain glycoprotein Emi-
lin1, responsible for promoting a4b1 integrin–dependent
cell adhesion, results in the proliferation of epithelial cells
and accelerated wound healing (Danussi et al, 2011). Simi-
larly, overexpression of the zinc ﬁnger transcription factor
Klf5 in epithelial cells result in enhanced cellular migration
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through a direct interaction with integrin-liked kinases,
which activates Akt (Yang et al, 2008). These results indi-
cate a central importance of AKT as a molecule acting down-
stream from multiple pathways involved in wound healing.
PTEN
The phosphatase and tensin homolog (PTEN) gene was
identiﬁed in 1997 as a tumor suppressor gene capable of
antagonizing proto-oncogenes as the PI3K (Maehama and
Dixon, 1998) (Maehama, 2007) (Stambolic et al, 1998).
This phosphatase has as a substrate PIP3 that is dephos-
phorylated into PIP2, which results in the controlling of
the AKT signaling activation. As a major regulator of the
PI3K signaling, the role of PTEN in the control of physio-
logical and pathological processes is becoming increas-
ingly clear. This is the case for autoimmunity and
lymphomagenesis (Newton and Turka, 2012), innate
immune responses in mouse liver ischemia (Kamo et al,
2012), normal lung morphogenesis, and the prevention of
lung carcinogenesis (Yanagi et al, 2007). Of interest for
this review, in skin homeostasis loss of Pten results in
progressive changes in the hair follicles with increased
thickness of the outer root sheet and the development of
multiple hyperproliferative lesions throughout the skin,
especially around the nose, mouth, eyes, paws, limbs, and
mucosa (Squarize et al, 2008). Such loss of function over
the control of cellular proliferation caused by deletion of
Pten denotes the importance of this tumor suppressor gene
for the maintenance of tissue homeostasis, yet also indi-
cates that transient downregulation of this tumor suppres-
sive pathway may be of interest for regenerative therapies.
Indeed, we have previously shown that excision of Pten
from the epidermis using a CRE recombinase driven by
the cytokeratin 14 promoter can dramatically inﬂuence the
recovery of a wounded skin by accelerating the healing
process (Fig. 1) (Squarize et al, 2010). As expected, dele-
tion of Pten results in over activity of the PI3K signaling
pathway and activation of the phosphorylated Akt and
pS6 (Fig. 2) in the wounded area. Expression of active
Akt and pS6, typically observed in the superﬁcial layers
of the epidermis (stratum corneum), was promptly upregu-
lated in the spinous and partially in the basal layer at the
transition skin, which is localized between normal skin
and the wound edge. Akt and pS6 (Fig. 2) were further
upregulated at the epithelial tongue throughout the entire
thickness of the epidermis. Skin wounds from control mice
also demonstrate an upregulation of Akt and pS6 in the tran-
sition and epithelial tongue, however much better compart-
mentalized within the differentiated layers of the epidermis
than mice presenting deletion of Pten (Fig. 2) (Squarize
et al, 2010). These ﬁndings suggest that physiological
downregulation of Pten may be required for proper skin
healing and that further downregulation of other members
of the PI3K signaling pathway, aiming at the activating
mTOR, may also be a viable strategy to inﬂuence skin
regeneration while preventing unwanted side effects.
The tuberous sclerosis proteins
The tuberous sclerosis genes TSC1 and TSC2 code for
two proteins named hamartin and tuberin, respectively.
Their main function is to control cell growth and cell divi-
sion. Both proteins also act as tumor growth suppressors
by antagonizing the mTOR signaling pathway through the
interaction with the Rheb1 GTPase. Loss of TSC1 or
TSC2 gene function is caused by sporadic genetic muta-
tions resulting in the genetic disorder known as tuberous
sclerosis complex leading the accumulation of active
Rheb1 and thereby constitutive activation of mTOR (Inoki
and Guan, 2009). Therefore, transient suppression of the
tuberous sclerosis complex constitutes a safe and attractive
approach to induce mTOR signaling.
Indeed, we have shown that targeted excision of Tsc1
using a genetically deﬁned approach exclusively to the
epidermis results in the in vivo activation of mTOR signal-
ing demonstrated by the phosphorylation of S6 protein, a
hallmark of mTOR activity (Fig. 2) (Squarize et al, 2010).
Moreover, by inhibiting the Tsc1 gene function and subse-
quently production of hamartin protein, we could observe
an accelerated wound healing of conditional knockout
mice with an overall reduction of the healing time of full
thickness wounds similar to the phenotype observed in
Pten conditional knockout mice (Fig. 3). Patients harbor-
ing mutations in the TSC gene develop hamartomas and
non-neoplastic proliferative disorders; however, they fail
to develop tumors such as those observed in patients with
Cowden disease, which present loss of function mutations
of the PTEN gene (Squarize et al, 2008). Similarly, long-
term follow-up of mice presenting targeted mutation for
Figure 1 Absence of Pten from epithelial cells of the skin resulted in
accelerated wound healing. Pten is the main regulator of the PI3K/mTOR
pathway. With the excision of Pten, epithelial cells proliferate and
migrate faster than the epithelial cells from control mice. Accordingly,
skin healing from K14Cre PtenF/F is dramatically accelerated after inci-
sional surgical wounding. As seen here, wound closure of mice group
with Pten epithelial-speciﬁc conditional deletion was completed by day
9, while control group exhibited wound closure by day 12 (P < 0.0001,
n = 8) (data are from Squarize et al, 2010)
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Tsc1 shows normal skin development, and lack of tumor
formation indicating that transient modulation of the PI3K
signaling at the level of the tuberous sclerosis protein
complex constitutes a viable and safe strategy to enhance
tissue repair.
Whereas interfering with the ability of normal regula-
tory mechanisms involved in the control of epithelial
growth and cellular division may increase cancer risk, and
hence, it should be carefully taken in consideration, we
have also observed that epithelial stem cells are endowed
with protective mechanisms capable of inducing stem cell
differentiation or senescence upon aberrant activation of
mTOR (Castilho et al, 2009). Thus, strategies aiming at
the indirect activation of mTOR though pharmacological
or genetic downregulation of TSC proteins may represent
a suitable strategy to enhance epithelial migration into the
wound bed, thereby reducing the overall healing time and
the development of secondary complications, without
increasing cancer risk.
Periostin
The process of epithelial migration during wound healing
is controlled not only by intrinsic factors, but also by
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Figure 2 mTOR pathway is activated during
the wound healing process. Upregulation of
mTOR (pS6) is found in the transitional and
epithelial tongue correspondent to the
proliferative and migratory anatomical areas of
normal wounds. In addition, histological
analyses of the wounds demonstrate the
upregulation of mTOR signaling on epithelial
cells derived from Pten and Tsc1 deletion
(K14Cre PtenF/F and K14Cre Tsc1F/F mice,
respectively), which resulted in increased re-
epithelization. (pS6, red (TRICT); ﬁbrin clot,
green (FITC); cells/nucleus, blue (DAPI) (data
are from Squarize et al, 2010)
Figure 3 Deletion of Tsc1 from the epithelial
cells of the skin resulted in acceleration of
healing. Tuberous sclerosis complex protein 1
(TSC1) forms a complex with TSC2. The
inactivation of TSC2/TSC1 complex leads to
the accumulation of the GTP-bound (active)
form of Rheb1, which in turn promotes the
direct activation of mTOR. Using a genetically
deﬁned approach, Tsc1 excision from the skin
(using K14Cre Tsc1F/F mice) resulted in
accelerated wound healing. The median wound
closure time in K14Cre Tsc1F/F mice was
9 days after wound, as compared to day 11 in
littermate control mice (P = 0.0150, n = 8)
(data are from Squarize et al, 2010)
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extrinsic stimuli available in the wounded site produced
during the process of blood clotting or released by the
stromal cells involved in the process of re-epithelializa-
tion. Periostin is one of the matricellular proteins normally
expressed in adult skin, which is highly upregulated dur-
ing wound healing (Hamilton, 2008) (Zhou et al, 2010)
(Nishiyama et al, 2011) (Elliott et al, 2012). In fact, ﬁbro-
blasts exposed to environmental changes found during
wound healing differentiate into myoﬁbroblasts, which
present an increased secretion of periostin (Zhou et al,
2010). This matricellular protein is endowed of unique
properties capable of responding to mechanical stress, as
initially observed in the periodontal ligament and perios-
teum, where mechanical stresses play a central role in the
dynamic of bone remodeling (Horiuchi et al, 1999). As a
component of the ECM, periostin is known to interact
with integrin molecules, thereby activating the PI3K sig-
naling pathway in tumor cells (Gillan et al, 2002) (Bao
et al, 2004). Recently, Ontsuka et al revealed that human
dermal ﬁbroblasts stimulated with recombinant periostin
lead to the activation of several kinases including AKT,
establishing the role of periostin in ﬁbroblast-driven
wound healing (Ontsuka et al, 2012). Although many
functions of periostin have been identiﬁed, the signaling
pathways involved in accelerated wound healing are still
unknown. We have recently characterized the effects of
periostin over epithelial cells at the biological and molecu-
lar levels (L.K. Rosselli-Murai and R.M. Castilho, manu-
script in preparation). In this study, we found that
periostin is capable of dramatically modulating the behav-
ior of epithelial cells in vitro by increasing their migratory
and proliferative capacity in a process that involves the
upregulation of the AKT/mTOR signaling pathway. There-
fore, the mitogenic and migratory capacity of epithelial
cells observed during wound healing may not be solely
driven by cell intrinsic signaling events, but it may rather
result from the cooperative signaling from both the epithe-
lial and mesenchymal components of the skin.
The emerging picture of the ﬁeld is that a diversity of
molecular signaling circuitries involved in the process of
wound healing ultimately converges on the activation of
the PI3K pathway resulting in activation of mTOR
(Fig. 4). Although the process of healing is multifactorial
and requires the cooperation between different cell types
along with the deposition and maturation of the ECM, the
sole enhancement of epithelial migration is feasible with
obvious beneﬁts for patients suffering of extensive
wounds. Therefore, modulation of the PI3K pathway may
represent a new therapeutic target for accelerating skin
regeneration and the closure of critical life-threatening
wounds.
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